z-logo
open-access-imgOpen Access
Advances in modelling gold nanoparticle radiosensitization using new Geant4-DNA physics models
Author(s) -
Elette Engels,
Samer Bakr,
David Bolst,
D. Sakata,
Nan Li,
Peter Lazarakis,
S. J. McMahon,
V. Ivanchenko,
Anatoly B. Rosenfeld,
S. Incerti,
Ioanna Kyriakou,
Dimitris Emfietzoglou,
Michael L. F Lerch,
Moeava Tehei,
Stéphanie Corde,
Susanna Guatelli
Publication year - 2020
Publication title -
physics in medicine and biology/physics in medicine and biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.312
H-Index - 191
eISSN - 1361-6560
pISSN - 0031-9155
DOI - 10.1088/1361-6560/abb7c2
Subject(s) - colloidal gold , nanoparticle , monte carlo method , in silico , materials science , nanoscopic scale , absorbed dose , nanotechnology , physics , radiation , chemistry , optics , mathematics , biochemistry , statistics , gene
Gold nanoparticles have demonstrated significant radiosensitization of cancer treatment with x-ray radiotherapy. To understand the mechanisms at the basis of nanoparticle radiosensitization, Monte Carlo simulations are used to investigate the dose enhancement, given a certain nanoparticle concentration and distribution in the biological medium. Earlier studies have ordinarily used condensed history physics models to predict nanoscale dose enhancement with nanoparticles. This study uses Geant4-DNA complemented with novel track structure physics models to accurately describe electron interactions in gold and to calculate the dose surrounding gold nanoparticle structures at nanoscale level. The computed dose in silico due to a clinical kilovoltage beam and the presence of gold nanoparticles was related to in vitro brain cancer cell survival using the local effect model. The comparison of the simulation results with radiobiological experimental measurements shows that Geant4-DNA and local effect model can be used to predict cell survival in silico in the case of x-ray kilovoltage beams.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here